About Us
At Freenome, we’re racing toward a world where cancer doesn’t take anyone by surprise. Since 2014, we’ve brought together molecular biology, machine learning and multi-omics to build early-detection blood tests that catch disease in its most treatable moments.
Our platform watches for the subtle signals your body sends — even before symptoms show. We believe every test, every dataset and every partnership moves us closer to making screening affordable, accessible and impactful, for everyone.
More than technology, we’re a community of scientists, engineers and mission-driven builders who wake up thinking about lives saved. Because when the problem is massive, you need to believe in the question: what if we changed the outcome? Now we’re making that belief our reality.
Learn more in this article from YourStory.